OneWorld Health To Become PATH Affiliate
“PATH and OneWorld Health (OWH) [on Friday] announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH’s mission of improving global health through innovation,” according to a PATH press release. The press release adds, “By becoming a PATH affiliate, OneWorld Health will be able to scale and accelerate its successful drug development efforts, which include developing a semisynthetic version of artemisinin, a key component in treating malaria, to help provide an affordable, stable source of the drug, alleviate shortages, and meet global demand” (12/16).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.